ATE305447T1 - Neue fettsäureanaloga - Google Patents
Neue fettsäureanalogaInfo
- Publication number
- ATE305447T1 ATE305447T1 AT01910259T AT01910259T ATE305447T1 AT E305447 T1 ATE305447 T1 AT E305447T1 AT 01910259 T AT01910259 T AT 01910259T AT 01910259 T AT01910259 T AT 01910259T AT E305447 T1 ATE305447 T1 AT E305447T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon
- fatty acid
- alkyl
- coor2
- proviso
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C391/00—Compounds containing selenium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/18—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20001123A NO328803B1 (no) | 2000-03-03 | 2000-03-03 | Nye fettsyreanaloger |
PCT/NO2001/000082 WO2001068582A1 (en) | 2000-03-03 | 2001-03-02 | Novel fatty acid analogous |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE305447T1 true ATE305447T1 (de) | 2005-10-15 |
Family
ID=19910832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01910259T ATE305447T1 (de) | 2000-03-03 | 2001-03-02 | Neue fettsäureanaloga |
Country Status (18)
Country | Link |
---|---|
US (1) | US7902399B2 (de) |
EP (1) | EP1265838B9 (de) |
JP (1) | JP5122050B2 (de) |
KR (3) | KR100940373B1 (de) |
CN (1) | CN1283611C (de) |
AT (1) | ATE305447T1 (de) |
AU (2) | AU3783501A (de) |
BR (1) | BR0108950A (de) |
CA (1) | CA2401757C (de) |
DE (1) | DE60113663T2 (de) |
DK (1) | DK1265838T3 (de) |
ES (1) | ES2250360T3 (de) |
HK (1) | HK1050182A1 (de) |
MX (1) | MX236472B (de) |
NO (1) | NO328803B1 (de) |
NZ (1) | NZ521137A (de) |
RU (1) | RU2288215C2 (de) |
WO (1) | WO2001068582A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO20004844L (no) * | 2000-09-27 | 2002-05-10 | Thia Medica As | Fettsyre analoger for behandling av proliferative hudsykdommer |
AU2003278602C1 (en) | 2002-06-20 | 2010-08-12 | Pronova Biopharma Norge As | Sulfur-containing phospholipid derivatives |
EP1718602A4 (de) * | 2004-01-30 | 2007-12-12 | Peplin Biolipids Pty Ltd | Therapeutische und trägermoleküle |
NO324533B1 (no) * | 2004-07-19 | 2007-11-19 | Thia Medica As | Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og et proteinmateriale, samt anvendelse derav. |
US7659242B2 (en) * | 2004-07-19 | 2010-02-09 | Thia Medica As | Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities |
ES2733353T3 (es) | 2007-11-09 | 2019-11-28 | Basf As | Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento |
NO20075894L (no) * | 2007-11-15 | 2009-05-18 | Thia Medica As | Redusert kjonnsmodning i fisk |
EP2147910A1 (de) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Neue Lipid-Verbindungen |
US8735436B2 (en) | 2009-05-08 | 2014-05-27 | Pronova Biopharma Norge As | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
SG10201509127YA (en) | 2010-11-05 | 2015-12-30 | Pronova Biopharma Norge As | Methods of treatment using lipid compounds |
CN105120842B (zh) | 2013-02-28 | 2020-12-01 | 普罗诺瓦生物医药挪威公司 | 包含脂质化合物、甘油三酯和表面活性剂的组合物以及使用它们的方法 |
WO2014140934A2 (en) | 2013-03-11 | 2014-09-18 | Life Science Nutrition As | Natural lipids containing non-oxidizable fatty acids |
AU2014228387B2 (en) | 2013-03-11 | 2016-09-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
EP3288550B1 (de) | 2015-04-28 | 2024-06-05 | Basf As | Strukturell von verbesserten schwefelhaltigen fettsäuren zu ihrer verwendung in der behandlung von nichtalkoholischer steatohepatitis |
IL308604A (en) | 2017-12-06 | 2024-01-01 | Basf As | Fatty acid antecedents for the treatment of nonalcoholic fatty liver disease |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2210230A1 (de) * | 1972-03-03 | 1973-09-06 | Kolmar Laboratories | Verwendung bestimmter thioaether als antimikrobielle und zytostatische mittel |
BE809894A (nl) | 1973-01-30 | 1974-07-18 | Antikleursluierstoffen voor fotografische kleurenmaterialen | |
JPS5531778B2 (de) * | 1973-02-15 | 1980-08-20 | ||
DE3620685A1 (de) | 1986-06-20 | 1987-12-23 | Henkel Kgaa | Neue mittel zur abdeckung unverletzter und/oder verletzter bereiche menschlicher oder tierischer haut |
MC1956A1 (fr) | 1987-07-22 | 1989-06-30 | Roussel Uclaf | Composés chimiques leurs procédés et intermédiaires de fabrication formulations pesticides les contenant et procédés les utilisant pour lutter contre des arthropodes et helminthes nuisibles |
US5268494A (en) * | 1988-05-10 | 1993-12-07 | Centre International De Recherches Dermatologiques C.I.R.D. | Sulphur-containing eicosanoides and their application in pharmacy and in cosmetics |
FR2631339B1 (fr) | 1988-05-10 | 1990-11-16 | Cird | Nouveaux eicosanoides sulfures et leur application en pharmacie et en cosmetique |
GB8813012D0 (en) * | 1988-06-02 | 1988-07-06 | Norsk Hydro As | Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals |
JPH0379659A (ja) | 1989-08-22 | 1991-04-04 | Mitsubishi Gas Chem Co Inc | 光学用成形材料 |
WO1991003542A1 (en) | 1989-09-11 | 1991-03-21 | Kao Corporation | Bleaching composition |
CA2030174C (en) * | 1990-01-10 | 1996-12-24 | Anthony H. Cincotta | Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
JP3079659B2 (ja) | 1991-08-07 | 2000-08-21 | 松下電器産業株式会社 | 車載用空気清浄器 |
US6602861B1 (en) | 1992-04-16 | 2003-08-05 | Research Corporation Technologies, Inc. | Acylated phospholipid drugs |
US5554646A (en) * | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
US5290960A (en) | 1993-02-25 | 1994-03-01 | The United States Of America As Represented By The Secretary Of The Navy | Diacetylenic phospholipids containing heteroatom near diacetylenic functionality for modulation of microstructure morphology |
DE69524639T2 (de) * | 1994-10-13 | 2002-08-08 | Peptech Ltd | Modifizierte mehrfach ungesättigte fettsäuren |
NO952796D0 (no) | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
GB2328155B (en) * | 1996-04-12 | 2000-08-02 | Peptide Technology Pty Limited | Methods of treating immunopathologies using polyunsaturated fattyacids |
CA2257084A1 (en) * | 1996-06-06 | 1997-12-11 | Anthony H. Cincotta | Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
EP1091934A2 (de) * | 1998-06-29 | 2001-04-18 | Parker Hughes Institute | Alkylketone als wirksame mittel gegen krebs |
WO2000030444A1 (en) | 1998-11-25 | 2000-06-02 | Vanderbilt University | Cationic liposomes for gene transfer |
FR2792312B1 (fr) | 1999-04-15 | 2001-06-08 | Oreal | Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation |
AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
NO20003591L (no) | 2000-07-13 | 2002-01-14 | Thia Medica As | Fettsyreanaloger for behandling av kreft |
NO20004844L (no) | 2000-09-27 | 2002-05-10 | Thia Medica As | Fettsyre analoger for behandling av proliferative hudsykdommer |
NO20006008L (no) | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
US20020188023A1 (en) | 2000-12-12 | 2002-12-12 | Michael Jorgensen | Compound |
GB0118517D0 (en) | 2001-07-30 | 2001-09-19 | Mitsubishi Tokyo Pharm Inc | Compound |
FR2828487B1 (fr) | 2001-08-09 | 2005-05-27 | Genfit S A | Nouveaux composes derives d'acides gras, preparation et utilisations |
AU2003278602C1 (en) | 2002-06-20 | 2010-08-12 | Pronova Biopharma Norge As | Sulfur-containing phospholipid derivatives |
US7659242B2 (en) | 2004-07-19 | 2010-02-09 | Thia Medica As | Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities |
-
2000
- 2000-03-03 NO NO20001123A patent/NO328803B1/no not_active IP Right Cessation
-
2001
- 2001-03-02 CA CA2401757A patent/CA2401757C/en not_active Expired - Fee Related
- 2001-03-02 NZ NZ521137A patent/NZ521137A/en not_active IP Right Cessation
- 2001-03-02 AU AU3783501A patent/AU3783501A/xx active Pending
- 2001-03-02 DE DE60113663T patent/DE60113663T2/de not_active Expired - Lifetime
- 2001-03-02 WO PCT/NO2001/000082 patent/WO2001068582A1/en active IP Right Grant
- 2001-03-02 US US10/220,502 patent/US7902399B2/en not_active Expired - Fee Related
- 2001-03-02 AU AU2001237835A patent/AU2001237835B2/en not_active Ceased
- 2001-03-02 KR KR1020087009732A patent/KR100940373B1/ko not_active IP Right Cessation
- 2001-03-02 ES ES01910259T patent/ES2250360T3/es not_active Expired - Lifetime
- 2001-03-02 EP EP01910259A patent/EP1265838B9/de not_active Expired - Lifetime
- 2001-03-02 CN CNB018071112A patent/CN1283611C/zh not_active Expired - Fee Related
- 2001-03-02 BR BR0108950-1A patent/BR0108950A/pt not_active Application Discontinuation
- 2001-03-02 DK DK01910259T patent/DK1265838T3/da active
- 2001-03-02 KR KR1020027011476A patent/KR100857626B1/ko not_active IP Right Cessation
- 2001-03-02 JP JP2001567680A patent/JP5122050B2/ja not_active Expired - Fee Related
- 2001-03-02 AT AT01910259T patent/ATE305447T1/de active
- 2001-03-02 MX MXPA02008629 patent/MX236472B/es active IP Right Grant
- 2001-03-02 RU RU2002123590/04A patent/RU2288215C2/ru not_active IP Right Cessation
- 2001-03-02 KR KR1020097020038A patent/KR100982228B1/ko not_active IP Right Cessation
-
2003
- 2003-03-31 HK HK03102294A patent/HK1050182A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE305447T1 (de) | Neue fettsäureanaloga | |
ATE548919T1 (de) | Fett- oder ölzusammensetzung | |
ATE516321T2 (de) | Zusammensetzungen mit fluorosubstituierten olefinen | |
KR900012592A (ko) | 치과용 충전재 | |
HUP0002174A2 (hu) | Nedvességszabályozó adalékot tartalmazó kompozíció selyempapírtermékekhez, ezt tartalmazó selyempapírtermékek és eljárás előállításukra, valamint e kompozíció alkalmazása | |
EP2336287A3 (de) | Zusammensetzungen mit fluorsubstituierten Olefinen | |
EP2277977A3 (de) | Zusammensetzungen mit fluorsubstituierten Olefinen | |
BR9910296A (pt) | Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado | |
WO2005089256A3 (en) | Antiangiogenic agents | |
ATE457970T1 (de) | Zusammensetzungen zur beseitigung von unangenehmen gerüchen | |
WO2007010281A3 (en) | Use of thiazole derivatives and analogues in disorders caused by free fatty acids | |
ES2421512T3 (es) | Composiciones orales que contienen compuestos antibacterianos bifenólicos | |
NO20043548L (no) | Anvendelse av flerumettede katoner for behandling av psoriasis | |
DE60137243D1 (de) | Fettsäure-analogen zur behandlung proliferierender hautstörungen | |
WO2005118636A3 (en) | Tgf derepressors and uses related thereto | |
RU2000103224A (ru) | Лишенные побочных эффектов производные простагландинов для лечения глаукомы | |
JP2010520242A5 (de) | ||
BRPI0601283A (pt) | composição para revestimento de pisos, aditivo para composição para revestimento de pisos, agente de nivelamento ou plastificante, e, método para melhorar o desempenho de nivelamento de uma composição para revestimento de pisos | |
EP1264594A3 (de) | Inhibitoren der Melaminherstellung und Hautpflegeprodukte, die solche Inhibitoren enthalten | |
BR0214917A (pt) | Composições que compreendem epotilonas e o uso das mesmas para o tratamento da sìndrome carcinóide | |
NO20082546L (no) | Anvendelse av fettsyreanaloger | |
JP2022113577A5 (de) | ||
BRPI0410926A (pt) | análogos de 3-oxa-8-azaprostaglandinas como agentes para reduzir a pressão intraocular | |
BR0309838A (pt) | composições microerbicidas e métodos de preparação e uso das mesmas | |
WO2004066760A3 (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1265838 Country of ref document: EP |